CBD.NZ
Cannasouth Ltd
Price:  
0.10 
NZD
Volume:  
204,091.00
New Zealand | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CBD.NZ WACC - Weighted Average Cost of Capital

The WACC of Cannasouth Ltd (CBD.NZ) is 7.6%.

The Cost of Equity of Cannasouth Ltd (CBD.NZ) is 8.25%.
The Cost of Debt of Cannasouth Ltd (CBD.NZ) is 4.45%.

Range Selected
Cost of equity 6.60% - 9.90% 8.25%
Tax rate 28.00% - 28.00% 28.00%
Cost of debt 4.00% - 4.90% 4.45%
WACC 6.1% - 9.0% 7.6%
WACC

CBD.NZ WACC calculation

Category Low High
Long-term bond rate 4.3% 4.8%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.44 0.75
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.60% 9.90%
Tax rate 28.00% 28.00%
Debt/Equity ratio 0.15 0.15
Cost of debt 4.00% 4.90%
After-tax WACC 6.1% 9.0%
Selected WACC 7.6%

CBD.NZ's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for CBD.NZ:

cost_of_equity (8.25%) = risk_free_rate (4.55%) + equity_risk_premium (5.60%) * adjusted_beta (0.44) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.